Elevance Health Q4 Earnings Call Highlights

CFO Mark Kaye reported adjusted diluted EPS of $3.33 for the fourth quarter and $30.29 for the full year. He said fourth-quarter results benefited from greater tax favorability than anticipated, increasing the full-year contribution from non-recurring items to $3.75 per share . Kaye added that solid underlying performance allowed the company to advance some investments originally planned for 2026 and to support workforce-related initiatives entering the year.Elevance Health established 2026 adjusted diluted ...